Implantable cardioverter-defibrillator therapy is indicated in all patients with ischaemic cardiomyopathy and severe systolic dysfunction: discussion
12 April 2026 (08:00 - 15:30)
Organised by: 
5 More presentations in this session
Professor C. Sticherling (Basel, CH)
Doctor J. Karvonen (Helsinki, FI)
Associate Professor G. Upadhyay (Chicago, US)
Access the full session
The Event
EHRA 2026
12 April - 14 April 2026
You may be interested in
Congress Session
